or Try an Advanced Search...

    Targeted Therapy Stocks List

    Symbol Grade Name % Change
    CRDF C Cardiff Oncology, Inc. 2.01
    IDYA C IDEAYA Biosciences, Inc. 3.42
    DCPH C Deciphera Pharmaceuticals, Inc. 3.31
    AVTX C Avalo Therapeutics, Inc. 6.41
    BCAB D BioAtla, Inc. 12.89
    CELC D Celcuity Inc. 0.95
    CLRB D Cellectar Biosciences, Inc. 0.33
    OLMA F Olema Pharmaceuticals, Inc. 1.22
    POAI F Predictive Oncology Inc. -9.04
    ATRA F Atara Biotherapeutics, Inc. -1.40
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
    Related Stock Lists: Medicine Clinical Medicine Cancer Biopharmaceutical Drugs Antineoplastic Drugs Biomarkers Biotechnology Oncology Precision Medicine Solid Tumors Advanced Solid Tumors Biology Blastoma Cancer Immunotherapy Cancer Treatment Cell Biology Chemotherapy Clinical Development Glioblastoma

    Related ETFs - A few ETFs which own one or more of the above listed Targeted Therapy stocks.

    Symbol Grade Name Weight
    SBIO C ALPS Medical Breakthroughs ETF 3.12
    CNCR D Loncar Cancer Immunotherapy ETF 2.54
    PTH D Invesco DWA Healthcare Momentum ETF 2.27
    BBP D BioShares Biotechnology Products Fund 1.89
    XBI D SPDR S&P Biotech ETF 1.77
    View all Targeted Therapy ETFs...
    Compare ETFs
    Compare BBP to XBI Compare CNCR to PTH Compare PTH to BBP

        Targeted Therapy Stocks Recent News

        Date Stock Title
        Apr 26 DCPH Diving Into Deciphera Pharmaceuticals
        Apr 25 CRDF Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
        Apr 25 POAI Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
        Apr 25 DCPH Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        Apr 24 BCAB BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
        Apr 24 POAI Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
        Apr 24 IDYA IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study
        Apr 24 DCPH Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        Apr 22 IDYA IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer
        Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
        Related Stock Lists: Medicine Clinical Medicine Cancer Biopharmaceutical Drugs Antineoplastic Drugs Biomarkers Biotechnology Oncology Precision Medicine Solid Tumors Advanced Solid Tumors Biology Blastoma Cancer Immunotherapy Cancer Treatment Cell Biology Chemotherapy Clinical Development Glioblastoma
        Targeted Therapy

        Targeted therapy is a type of cancer treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. It works by targeting the molecules and pathways that are involved in the growth and spread of cancer cells. Targeted therapy is used to treat many types of cancer, including breast, lung, and colorectal cancer.

        Browse All Tags